There is more to come as the Limfinity portfolio of solutions expands into Machine Learning and innovative new information systems for the medical practitioner.
FREDERICK, Md. (PRWEB) July 24, 2018
RURO, Inc., the creator of the Limfinity® laboratory software framework, reported triple digit revenue growth in 2018. Limfinity® Version 7 was released earlier this year, and the RURO development team has continued to expand the Limfinity® portfolio of solutions, including the quickly growing LimitLIS® Laboratory Information System, Study Manager™, and the upcoming Limfinity ML™.
Limfinity® has grown more than 110% year over year and additional solid results are expected. Limfinity® Version 7 contained a key set of updates enhancing the user and admin experience for RURO’s customer base. This new version contained a revamped user interface, improvements to UI grids, and a host of other innovations to make Limfinity® run faster and more smoothly than ever before.
Key to Limfinity® growth were new contracts with the US Army, a major national medical system, a top Swiss pharma company, and multiple leading cancer centers. RURO’s LimitLIS® added many new live customer sites, averaging 2.5 per month. The LimitLIS® Toxicology Edition, with its modern user experience and rapid implementation, was the most deployed version of Limfinity®.
“Limfinity customers are popping up everywhere,” says Tom Dolan, RURO’s Chief Executive Officer. “Most importantly, their labs are popping with modernity, efficiency, lowered infrastructure costs, and a new way to work. There is more to come as the Limfinity portfolio of solutions expands into Machine Learning and innovative new information systems for the medical practitioner.”
For more information, visit http://www.ruro.com or speak to a representative at (888) 881-7876.